Liver Cancer Cell Lines
Database

LCCL to predict drug response

Correlation Mutation/CNA-Drug

GeneFilter by null	DrugFilter by null	Drug AUC ratio M vs NM	Pvalue
ABL1	Alisertib	0.80	0.042
BCOR	Alisertib	1.17	0.039
FAT4	Alisertib	1.15	0.039
TP53	Alisertib	0.88	0.028
FAT3	Alvespimycin	0.81	0.011
MYH9	Alvespimycin	0.72	0.021
TRIP11	Alvespimycin	0.64	0.031
FGFR1OP	BLU.9931	0.84	0.044
ROS1	BLU.9931	0.89	0.044
TSC1.TSC2	BLU.9931	1.08	0.023
UBR5	BLU.9931	0.81	0.028
CREBBP	Bortezomib	0.45	0.028
HLA.A	Bortezomib	1.59	0.034
NUMA1	Bortezomib	0.49	0.044
ERBB4	Brivanib	1.05	0.038
FGFR1	Brivanib	1.06	0.028
HLA.A	Brivanib	0.94	0.028
KEAP1	Brivanib	1.04	0.029
MAP3K13	Brivanib	0.96	0.044
MLLT10	Brivanib	1.05	0.037
MYH9	Brivanib	0.96	0.033
NRF2.pathway	Brivanib	1.03	0.050
RB1	Brivanib	0.96	0.038
TFEB	Brivanib	0.94	0.031
UBR5	Brivanib	0.95	0.037

Codebase Soc. Coop.
info@codebase.it